Adelman Robert J
Insider CIK 1329161 · DTIL Director, 10% owner · IMPL 10% owner · MTCR Director, 10% owner · CMPI 10% owner · AKRO 10% owner · ELEV 10% owner · ALXO 10% owner · ARTV 10% owner · RYZB 10% owner · VTYX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-22 | 214,692 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-22 | 843,592 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-22 | 214,692 | — | $0 | 1,058,284 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-22 | 416,666 | $12.00 | $5.00M | 1,936,637 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-22 | 461,687 | — | $0 | 1,519,971 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-22 | 843,592 | — | $0 | 843,592 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 216,127 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 1,123,862 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-21 | 3,786,957 | — | $0 | 0 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 247,343 | — | $0 | 5,158,162 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 1,123,862 | — | $0 | 4,910,819 | SEC↗ |
| RYZB RayzeBio, Inc. | C Conversion | 2023-09-19 | 2023-09-21 | 3,786,957 | — | $0 | 3,786,957 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 13,301 | — | $0 | 13,301 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 13,301 | — | $0 | 13,301 | SEC↗ |
| ELEV Elevation Oncology, Inc. | S Sale | 2022-05-25 | 2022-05-27 | 702,737 | $4.12 | $2.90M | 1,905,430 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-16 | 2022-05-17 | 95,800 | $10.45 | $1.00M | 2,155,930 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-13 | 2022-05-17 | 35,850 | $10.45 | $374.6K | 2,251,730 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-12 | 2022-05-12 | 124,525 | $10.39 | $1.29M | 2,287,580 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-11 | 2022-05-12 | 17,700 | $10.38 | $183.7K | 2,412,105 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-10 | 2022-05-12 | 18,676 | $10.38 | $193.9K | 2,429,805 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-09 | 2022-05-09 | 17,600 | $10.37 | $182.5K | 2,448,481 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-06 | 2022-05-09 | 48,334 | $10.37 | $501.2K | 2,466,081 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-05 | 2022-05-09 | 20,743 | $10.37 | $215.1K | 2,514,415 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-04 | 2022-05-04 | 37,500 | $10.37 | $388.9K | 2,535,158 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-03 | 2022-05-04 | 79,475 | $10.37 | $824.2K | 2,572,658 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-05-02 | 2022-05-04 | 153,700 | $10.38 | $1.60M | 2,652,133 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-29 | 2022-04-29 | 69,230 | $10.38 | $718.6K | 2,805,833 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-28 | 2022-04-29 | 73,400 | $10.38 | $761.9K | 2,875,063 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-27 | 2022-04-29 | 47,396 | $10.38 | $492.0K | 2,948,463 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-26 | 2022-04-26 | 64,683 | $10.38 | $671.4K | 2,995,859 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-25 | 2022-04-26 | 27,668 | $10.39 | $287.5K | 3,060,542 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-22 | 2022-04-26 | 37,430 | $10.39 | $388.9K | 3,088,210 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-21 | 2022-04-21 | 62,200 | $10.38 | $645.6K | 3,125,640 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-20 | 2022-04-21 | 85,611 | $10.39 | $889.5K | 3,187,840 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | S Sale | 2022-04-19 | 2022-04-21 | 399,923 | $10.42 | $4.17M | 3,273,451 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-25 | 3,289,742 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-25 | 395,027 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion | 2021-10-25 | 2021-10-25 | 3,684,769 | — | $0 | 3,684,769 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | P Buy | 2021-10-25 | 2021-10-25 | 312,500 | $16.00 | $5.00M | 3,997,269 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-10-25 | 2021-10-26 | 540,667 | $1.49 | $805.6K | 2,443,421 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-10-22 | 2021-10-26 | 75,035 | $1.64 | $123.1K | 2,984,088 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 8,380,034 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 625,000 | $16.00 | $10.00M | 2,608,167 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,983,167 | — | $0 | 1,983,167 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,845,942 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,201,930 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 13,233,885 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 0 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 5,876,034 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 2,309,791 | — | $0 | 2,309,791 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 450,000 | $15.00 | $6.75M | 2,759,791 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 0 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 472,250 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 396,089 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 230,000 | $13.00 | $2.99M | 230,000 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 2,829,123 | — | $0 | 3,059,123 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 3,644,624 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 12,500,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 8,753,350 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | P Buy | 2020-08-11 | 2020-08-12 | 200,000 | $15.00 | $3.00M | 3,673,374 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion | 2020-08-11 | 2020-08-12 | 3,473,374 | — | $0 | 3,473,374 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 2,398,588 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 3,100,020 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 78,175 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 490,411 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 3,000 | $19.00 | $57.0K | 99,406 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 850,000 | $19.00 | $16.15M | 5,268,325 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 3,941,949 | — | $0 | 4,418,325 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 78,175 | — | $0 | 96,406 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 3,100,020 | — | $0 | 3,969,789 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-16 | 2020-07-21 | 1,052,950 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-07-06 | 2020-07-06 | 4,603 | $33.83 | $155.7K | 3,033,552 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-07-02 | 2020-07-06 | 3,800 | $33.63 | $127.8K | 3,038,155 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-07-01 | 2020-07-06 | 108,064 | $34.45 | $3.72M | 3,041,955 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-03-06 | 2020-03-06 | 1,800 | $23.79 | $42.8K | 3,150,019 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-03-05 | 2020-03-06 | 8,500 | $23.53 | $200.0K | 3,151,819 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-03-04 | 2020-03-06 | 35,650 | $23.81 | $848.8K | 3,160,319 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-03-03 | 2020-03-03 | 6,401 | $23.00 | $147.2K | 3,195,969 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-03-02 | 2020-03-03 | 10,297 | $23.06 | $237.4K | 3,202,370 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-28 | 2020-03-03 | 5,100 | $21.30 | $108.6K | 3,212,667 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-27 | 2020-02-27 | 1,781 | $22.54 | $40.1K | 3,227,767 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-26 | 2020-02-27 | 2,523 | $22.44 | $56.6K | 3,229,548 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-25 | 2020-02-27 | 1,600 | $23.67 | $37.9K | 3,232,071 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-12 | 2020-02-12 | 6 | $27.14 | $163 | 3,233,671 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-11 | 2020-02-12 | 2,184 | $27.05 | $59.1K | 3,233,677 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-10 | 2020-02-12 | 7,836 | $27.08 | $212.2K | 3,225,861 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-06 | 2020-02-10 | 6,102 | $27.03 | $164.9K | 3,233,697 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-05 | 2020-02-06 | 28,608 | $25.99 | $743.5K | 3,239,799 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-02-04 | 2020-02-06 | 53,731 | $25.65 | $1.38M | 3,268,407 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-13 | 2020-01-14 | 494,000 | $20.23 | $9.99M | 3,322,138 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-08 | 2020-01-10 | 15,677 | $19.86 | $311.3K | 3,816,138 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-07 | 2020-01-08 | 31,000 | $20.17 | $625.3K | 3,831,815 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-06 | 2020-01-08 | 42,221 | $19.64 | $829.2K | 3,862,815 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-03 | 2020-01-06 | 12,498 | $19.30 | $241.2K | 3,905,036 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2020-01-02 | 2020-01-06 | 23,000 | $19.94 | $458.6K | 3,917,534 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2019-12-31 | 2020-01-03 | 14,324 | $23.96 | $343.2K | 3,940,534 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 10,666,667 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 722,737 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 235,099 | — | $0 | 3,954,858 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2019-06-24 | 2019-06-25 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 3,469,759 | — | $0 | 3,719,759 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-01 | 998,004 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion deriv | 2019-04-01 | 2019-04-01 | 8,000,000 | — | $0 | 0 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-01 | 467,518 | — | $0 | 4,265,141 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | C Conversion | 2019-04-01 | 2019-04-01 | 3,747,623 | — | $0 | 3,797,623 | SEC↗ |
| DTIL PRECISION BIOSCIENCES INC | P Buy | 2019-04-01 | 2019-04-01 | 50,000 | $16.00 | $800.0K | 50,000 | SEC↗ |